Humoral Response to SARS-CoV-2-Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis

mRNA-based SARS-CoV-2 vaccines offer a preventive strategy against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections that is of interest in the care of patients on hemodialysis (HDP). We measured humoral immune responses in 72 HDP after standard vaccination with two doses of th...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Vaccines (Basel)
Main Authors: Jahn, Michael, Korth, Johannes, Dorsch, Oliver, Anastasiou, Olympia Evdoxia, Sorge-Hädicke, Burkhard, Tyczynski, Bartosz, Gäckler, Anja, Witzke, Oliver, Dittmer, Ulf, Dolff, Sebastian, Wilde, Benjamin, Kribben, Andreas
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Communication
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8070660/
https://ncbi.nlm.nih.gov/pubmed/33918085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9040360
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki